Type 2 Diabetes

Showing NaN - NaN of 74

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Type 2 Diabetes Trial in Chicago (Intensive education and lifestyle support, Standard of Care control group)

Completed
  • Type 2 Diabetes
  • Intensive education and lifestyle support
  • Standard of Care control group
  • Chicago, Illinois
    Cook County Health Clinics
May 8, 2017

Type 2 Diabetes Trial in Worldwide (Insulin glargine/lixisenatide (HOE901/AVE0010), Insulin glargine (HOE901), Metformin

Completed
  • Type 2 Diabetes
  • Insulin glargine/lixisenatide (HOE901/AVE0010)
  • +2 more
  • Birmingham, Alabama
  • +235 more
Mar 31, 2017

Type 2 Diabetes Trial in Worldwide (Insulin glargine/lixisenatide Fixed Ratio Combination, Insulin glargine (HOE901),

Completed
  • Type 2 Diabetes
  • Insulin glargine/lixisenatide Fixed Ratio Combination
  • +3 more
  • Phoenix, Arizona
  • +272 more
Mar 31, 2017

Obstructive Sleep Apnea, Type 2 Diabetes Trial in Chicago (active CPAP Therapy, sham CPAP therapy)

Completed
  • Obstructive Sleep Apnea
  • Type 2 Diabetes
  • active CPAP Therapy
  • sham CPAP therapy
  • Chicago, Illinois
    The University of Chicago
Feb 24, 2017

Type 2 Diabetes, Renal Insufficiency Trial in Chicago, Maywood (0.5 units/kg daily insulin, 0.25 units/kg daily insulin)

Completed
  • Type 2 Diabetes
  • Renal Insufficiency
  • 0.5 units/kg daily insulin
  • 0.25 units/kg daily insulin
  • Chicago, Illinois
  • +2 more
Mar 9, 2017

Type 2 Diabetes Trial in Worldwide (Dapagliflozin, Metformin XR)

Completed
  • Type 2 Diabetes
  • Birmingham, Alabama
  • +98 more
Jan 5, 2017

Type 2 Diabetes, Obesity Trial in United States (EndoBarrier, Sham Procedure)

Terminated
  • Type 2 Diabetes
  • Obesity
  • EndoBarrier
  • Sham Procedure
  • Birmingham, Alabama
  • +24 more
Dec 2, 2016

Type 2 Diabetes Trial in United States (Bydureon, Placebo)

Completed
  • Type 2 Diabetes
  • Anaheim, California
  • +28 more
Dec 5, 2016

Type 2 Diabetes Trial in Worldwide (ITCA 650, ITCA )

Completed
  • Type 2 Diabetes
  • ITCA 650
  • ITCA placebo
  • Chandler, Arizona
  • +41 more
Jan 26, 2017

Type 2 Diabetes Trial in Worldwide (Dapagliflozin, Placebo-matching dapagliflozin)

Completed
  • Type 2 Diabetes
  • Birmingham, Alabama
  • +328 more
Dec 2, 2016

Type 2 Diabetes Trial in Worldwide (Lixisenatide (AVE0010), Insulin glulisine QD, Insulin glulisine TID)

Completed
  • Type 2 Diabetes
  • Lixisenatide (AVE0010)
  • +4 more
  • Sun City, Arizona
  • +198 more
Nov 4, 2016

Type 2 Diabetes Trial in Worldwide (Dapagliflozin, Placebo matching Dapagliflozin)

Completed
  • Type 2 Diabetes
  • Birmingham, Alabama
  • +297 more
Nov 10, 2016

Impact of Exenatide on Sleep Duration

Unknown status
  • Type 2 Diabetes
  • Chicago, Illinois
  • +1 more
Sep 1, 2016

Type 2 Diabetes Trial in Worldwide (ITCA 650 60 mcg/day, sitagliptin)

Completed
  • Type 2 Diabetes
  • Birmingham, Alabama
  • +53 more
May 13, 2016

Type 2 Diabetes, Cardiovascular Disease Trial in Worldwide (TAK-875, TAK-875 Placebo)

Terminated
  • Type 2 Diabetes
  • Cardiovascular Disease
  • Birmingham, Alabama
  • +587 more
Oct 15, 2015

Obesity, Cardiovascular Disease, Type 2 Diabetes Trial in Chicago (Sleeve Gastrectomy)

Completed
  • Obesity
  • +4 more
  • Sleeve Gastrectomy
  • Chicago, Illinois
    Northwestern University
Sep 30, 2015

Type 2 Diabetes Trial in United States (ITCA 650, ITCA )

Completed
  • Type 2 Diabetes
  • ITCA 650
  • ITCA placebo
  • Birmingham, Alabama
  • +121 more
Jul 28, 2015

Type 2 Diabetes Trial in Worldwide (MBX-102, Placebo, Actos)

Completed
  • Type 2 Diabetes
  • Jonesboro, Arkansas
  • +66 more
Apr 29, 2015

Type 2 Diabetes Trial in United States (Mitoglitazone, Pioglitazone, Placebo)

Completed
  • Type 2 Diabetes
  • Huntsville, Alabama
  • +23 more
Apr 6, 2015

Type 2 Diabetes Trial in United States (ITCA 650, Exenatide Injection, Ex Inj/ITCA 650)

Completed
  • Type 2 Diabetes
  • ITCA 650
  • +2 more
  • Chino, California
  • +49 more
Mar 23, 2015

Type 2 Diabetes, Hypogonadism Trial in United States (Androgel (testosterone gel))

Completed
  • Type 2 Diabetes
  • Hypogonadism
  • Androgel (testosterone gel)
  • Birmingham, Alabama
  • +69 more
Jan 19, 2015

A 2-Month Safety Follow-Up Trial

Completed
  • Type 1 Diabetes
  • Type 2 Diabetes
  • Birmingham, Alabama
  • +149 more
Dec 1, 2014

Postpartum Glucose Tolerance With Levonorgesterel IUD Use in

Completed
  • Gestational Diabetes
  • +3 more
  • Mirena (Levonorgestrel IUD)
  • Paragard (Copper IUD ) or Tubal Ligation
  • Chicago, Illinois
    Northwestern Medical Faculty Foundation; Northwestern Memorial H
Nov 19, 2014